Farmacogenetica in de dagelijkse praktijk

With the exception of a few medical specialties, the implementation of pharmacogenetic tests in daily practice has thus far been limited.

The Royal Dutch Pharmacists Association (KNMP) has developed pharmacogenetics-based therapeutic dose recommendations for 80 medicinal product combinations on the basis of a systematic literature review.

Genotyping of patients can take place on a reactive or pre-emptive basis; the advantage of pre-emptive genotyping is that it provides genetic information the moment a medicinal product is prescribed.

Clinical decision support software is crucial to implement pharmacogenetics into daily practice.

Conflict of interest and financial support: potential conflicts of interest have been reported for this article. ICMJE forms provided by the authors are available online along with the full text of this article.